Efficacy of Ondansetron as a Prophylactic Anti-Hypotensive Pharmacologic Intervention Among Obese Parturients Undergoing Spinal Anesthesia for Cesarean Delivery
Abstract
Background and Purpose
Obesity has been identified as a risk factor for hypotension after spinal anesthesia among parturients undergoing cesarean delivery. Although researchers have demonstrated prophylactic administration of ondansetron as efficacious in attenuating maternal hypotension following spinal anesthesia, no studies have examined the efficacy of prophylactic ondansetron in the high risk population of obese parturients. The primary objective of this study was to assess the efficacy of the novel application of ondansetron as a prophylactic anti-hypotensive pharmacologic intervention among obese parturients in order to facilitate practice recommendations that aim to reduce maternal-fetal risk associated with the administration of spinal anesthesia for cesarean delivery.
Methods
Retrospective chart analyses of 46 patients with BMI > 30 were conducted between August 1, 2014 and May 10, 2015 to determine whether the intravenous administration of 4 mg ondansetron prior to the induction of spinal anesthesia reduced frequency of vasopressor administration during cesarean section.
Results
The incidence of vasopressor administration among patients who received prophylactic ondansetron was 35.7%, whereas 46.9% of patients who did not receive prophylactic ondansetron required vasopressor administration (χ2 = 0.144, df = 1, p = 0.704).
Conclusions
Obese parturients undergoing spinal anesthesia for cesarean delivery demonstrated improvements in hemodynamic stability when prophylactically treated with ondansetron.
References
¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬¬___________________________________________________________________________
2 Centers for Disease Control and Prevention (CDC). Behavioral risk factor surveillance system. 2013. http://www.cdc.gov/brfss/index.htm. Accessed March 22, 2015.
___________________________________________________________________________
3 Levi J, Segal L, St. Laurent R, et al. F as in Fat: How Obesity Threatens America’s Future. Princeton, NJ: Robert Wood Johnson Foundation; 2012.
___________________________________________________________________________
4 Ogden CL, Carroll MD, Kit BK, et al. Prevalence of obesity among adults: United States, 2011-2012. NCHS data brief no. 131. 2013. http://www.cdc.gov/nchs/data/databriefs/db131.pdf. Accessed March 17, 2015.
___________________________________________________________________________
5 Centers for Disease Control and Prevention (CDC). Pregnancy complications. 2014. http://www.cdc.gov/reproductivehealth/maternalinfanthealth/pregcomplications.htm#n5. Accessed March 11, 2015.
___________________________________________________________________________
6 Chu SY, Bachman DJ, Callaghan WM, et al. Association between obesity during pregnancy and increased use of healthcare. N Engl J Med. 2008;358(14):1444–53.
___________________________________________________________________________
7 Tan C, Sia AC. Anesthesia considerations in the obese gravida. Semin Perinatal. 2011;35(6):350–5, 350.
___________________________________________________________________________
8 Nani F, Torres M. Correlation between the body mass index (BMI) of pregnant women and the development of hypotension after spinal anesthesia for cesarean section. Rev Bras Anest. 2011;61(1):21–30.
___________________________________________________________________________
9 Borgeat A, Ekatodramis G, Schenker C A. Postoperative nausea and vomiting in regional anesthesia. Anesthesiology 2003;98:530–547.
___________________________________________________________________________
10 Sahoo T, SenDasgupta C, Goswami A, et al. Reduction in spinal-induced hypotension with ondansetron in parturients undergoing caesarean section: A double-blind, randomized, placebo-controlled study. International Journal of Obstetric Anesthesia. 2012;21(1):24–8.
___________________________________________________________________________
11 Wang M, Zhuo, L, Wang Q, et al. Efficacy of prophylactic intravenous ondansetron on the prevention of hypotension during cesarean delivery: A dose-dependent study. Int J Clinic Exp Med. 2014;7(12):5210–5216.
___________________________________________________________________________
12 Liu SS, McDonald SB. Current issues in spinal anesthesia. Anesthesiology 2001;94:888–906.
___________________________________________________________________________
13 CDC. Overweight and obesity. 2014. http://www.cdc.gov/obesity/data/adult.html. Accessed March 17, 2015.
___________________________________________________________________________
14 Wang Q, Zhuo L, Shen MK, et al. Ondansetron preloading with crystalloid infusion reduces maternal hypotension during cesarean delivery. Am J Perinatol. 2014;31(10):913–22.
___________________________________________________________________________
15 Cooper GM, McClure JH. Anaesthesia. In Saving Mothers’ Lives: Reviewing maternal deaths due to make pregnancy safer. Br J Anaesth. 2008;100(1):17–22.
___________________________________________________________________________
16 Butwick A, Carvalho B, Danial C, et al. Retrospective analysis of anesthetic interventions for obese patients undergoing elective cesarean delivery. J Clin Anesth. 2010;22(7):519–26.
___________________________________________________________________________
17 Edomwonyi NP, Osaigbovo PE. Incidence of obesity in parturients scheduled for caesarean section, intra-operative complications, management and outcome. East Afr Med J. 2006;83(4):112–19.
___________________________________________________________________________
18 Horikawa Y, Fukuda H, Kawakami T, et al. The effect of obesity on spinal anesthesia for cesarean section. Masui. 2001;50(11):1205–08.
___________________________________________________________________________
19 Johnson D. Management of cesarean delivery in the morbidly obese woman. Contemporary OB/GYN. 2012;57(10):57–61. http://contemporaryobgyn.modernmedicine.com/contemporary-obgyn/news/modernmedicine/modern-medicine-feature-articles/management-cesarean-delivery.
___________________________________________________________________________
20 Rodrigues FR, Brandao MJ. Regional anesthesia for cesarean section in obese pregnant women: A retrospective study. Brazilian Journal of Anesthesiology 2001;61(1):13–20.
___________________________________________________________________________
21 Roofthooft E. Anesthesia for the morbidly obese parturient. Curr Opin Anesth. 2009;22(3):341–6.
___________________________________________________________________________
22 Vricella L, Louis J, Mercer B, et al. Anesthesia complications during scheduled cesarean delivery for morbidly obese women. Am J Obstet Gynecol. 2010;203(3):276.e1–276.e5.
___________________________________________________________________________
23 HHS (US Department of Health and Human Services). Office of Disease Prevention & Health. Healthy People 2020 topics & objectives. 2011. http://healthypeople.gov/2020.
___________________________________________________________________________
24 Campbell, I. Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations. Stat Med. 2007;26:3661–75.
___________________________________________________________________________
25 Cochran, W. G. The 2 test of goodness of t. Ann Math Statist. 1952;25:315–45.
___________________________________________________________________________
26 Fisher, R. A. The logic of inductive inference. J Royal Stat. 1934;98:39–54.
___________________________________________________________________________
Keywords
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors agree to the Creative Commons License listed below, which can be viewed by clicking the link below.
This work will be licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.